Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 95 for “"PDE4"”.
-
Characterisation of a novel PDE4 and the modification of PDE4 function by phosphorylation and protein-protein interaction
… means of cAMP degradation is by PDE enzymes. The PDE4 family represents the major cAMP-hydrolysing activity in many cells. Four genes encode the PDE4 isoforms and over twenty have now been characterised. Each isoform differs by virtue of a unique N-terminal intra-cellular targeting region, and by …
-
Studies on PDE4 cyclic AMP-specific phosphodiesterases
… adenosine-3',5'-cyclic monophosphate. The PDE4 family is complex, consisting of four genes, each of which is alternatively spliced. Understanding the functional significance of the multiple species is crucial so as to enable the development of novel drugs to modulate their activities for …
-
Compartmentalized cAMP Signaling via the PDE4-Popeye Protein Complex
… such a complex existed that contained POPDC and PDE4. This thesis begins with characterisation of the molecular interaction between POPDC1 and PDE4A. It was hypothesised that a signalling complex containing POPDC1 and PDE4A would be formed as a regulatory mechanism to control cAMP concentrations …
-
PDE4 inhibition: a novel therapeutic strategy in liver fibrosis.
… by an increase in phosphodiesterase 4 (PDE4), a cAMP degrading enzyme. We also showed that PDE4 inhibition by Rolipram attenuated fibrogenic signaling in a bile duct ligation liver fibrosis rat model. More recent studies done by our group showed that PDE4 inhibition by Rolipram …
-
Investigating bifunctional protein degraders to silence PDE4 activity in disease
Abstract not currently available.
-
The intracellular targeting and regulation of PDE4 cyclic AMP-specific phosphodiesterase enzymes
… cAMP-dependent processes. The cAMP-specific PDE4 enzyme family are encoded by four genes (PDE4A, -B, -C and -D) which each generate a number of isoenzymes by alternative 5' mRNA splicing. This process gives rise to PDE4 isoenzymes with unique extreme NH2-terminal splice regions, one or two …
-
DISC1 & GSK3β modulate PDE4 activity: functional integration of psychiatric associated signalling pathways
… Amongst these binding proteins are two enzymes, PDE4 and GSK3β, that were originally implicated in psychiatric disease by virtue of their inhibition by psychoactive drugs. PDE4 enzymes are inhibited by rolipram, which possesses anti-depressant and anti-psychotic activity, while GSK3β is one of …
-
Pathogenic role of phosphodiesterase 4 (pde4) in the development of alcohol induced hepatic steatosis.
… that increased expression of hepatic PDE4, which specifically hydrolyzes and decreases cAMP levels, plays a pathogenic role in the development of liver injury. Hence, the aim of this study was to examine the effect of alcohol on PDE4 expression in the liver and its potential role in …
-
Impaired Cardiac cAMP-specific PDE4, β1-AR, and NE in an Ischemia-Reperfusion Rat Model
… by measuring NE, β-AR, and perhaps indirectly PDE4 to give an intracellular aspect on SNS signaling. A 20 minute ischemia-reperfusion was induced in a rat model with physiological measurements at 2-5 weeks post IR. At 3 weeks post IR, rats displayed increased PDE4 expression, decreased β 1-AR …
-
Planejamento assistido por computador e síntese de potenciais inibidores seletivos de PDE4 baseados em produtos naturais
… flavonoid with remarkable selectivity for PDE4B isoform in comparison with PDE4A was isolated. This target can be highlighted as a promising alternative for the treatment of diseases as asthma and chronical obstructive pulmonary disease. Nonetheless, the structure of the flavonoid has some …
-
The potential of inhaled albumin nanoparticles as a delivery strategy to improve the therapeutic profile of PDE4 inhibitors
… RFM as a delivery strategy for a prototype PDE4 inhibitor. This body of work focused on (i) fabrication and characterisation of RFM in albumin nanoparticles (HSA-NPs); (ii) formulation of the NPs within respirable microparticles; (iii) design and application of in vitro and in vivo models of …
-
Binding of phosphodiesterase-4 inhibitor (R)-[carbon-11]rolipram in obese and diabetic rats: Effect of diet and noradrenergic modulation
Phosphodiesterase type-4 (PDE4) belongs to a family of enzymes responsible for the hydrolysis of cyclic adenosine 3',5'-monophosphate (cAMP) in the body. Activity and density of PDE4 are regulated by endogenous cAMP. The obese and diabetic disease states are associated with sympathetic nervous …
-
In vivo evaluation of (R)- and (S)-[carbon-11]rolipram for imaging cardiac phosphodiesterase-4 enzymes: Characterization and applications in rat models of heart failure
… (cAMP)-mediated phosphodiesterase 4 (PDE4) signaling. Comprehensive study of the intracellular mechanism involved in the progression of heart failure is hindered by the limitations of in vitro techniques. Intracellular cAMP levels regulate PDE4 expression and activity. Positron …
-
Phosphodiesterase-4 in the Brain: Effects of Pharmacological Inhibition and Mutation of DISC1
The effects of treatment with PDE4 inhibitors on cAMP/pCREB signaling, hippocampal neurogenesis and immobility in forced-swim test and the effects of DISC1 mutation on cAMP/pCREB signaling, PDE4 subtypes and PDE4 activity and high-affinity rolipram binding state were determined. Acute treatment …
-
Characterization of cAMP-Specific Phosphodiesterase-4 (R)-[11C]Rolipram Small Animal Positron Emission Tomography and Application in a Streptozotocin-Induced Model of Hyperglycemia
… was used to assess phosphodiesterase-4 (PDE4) alterations in a high fat diet (HFD), streptozotocin (STZ) induced model of hyperglycemia in rats. Prior to investigation in the animal model, characterization of (R)-[11C]rolipram small animal PET was completed. (R)-[11C]Rolipram binds …
-
Phosphodiesterase 4 isoforms in macrophage development and function
Phosphodiesterase 4 (PDE4) is a family of around 20 cyclic AMP (cAMP) hydrolysing enzymes. Expression of each isoform is regulated in a tissue and developmental specific manner. Such regulation suggests as yet undefined functions for each isoform. Understanding these functions will highlight likely …
-
Biochemical investigation of phosphodiesterase type IV post-translational modification, cellular localisation and interaction with associated binding proteins
… In this study post-translational-modification of PDE4 isoforms is investigated. SUMOylation is a relatively newly identified post-translational modification that is known to regulate the structure and function of its substrates. PDE4 isoforms of the PDE4A and 4D subfamilies are SUMOylated by an E3 …
-
Post-translational Modification and Sequestration of cAMP-specific Phosphodiesterase 4 in signalling complexes
… in cells. The cAMP-specific phosphodiesterase-4 (PDE4) is encoded by four different genes (PDE4A, PDE4B, PDE4C and PDE4D), which generate over 16 different isoforms by alternative 5' mRNA splicing. This process gives rise to PDE4 isoforms with unique N-terminal region, complete or truncated …
-
The Effect of Phosphodiesterase Inhibitors on the Induction of Gene Expression by Long-Acting beta2-Adrenoceptor Agonists and Glucocorticoids
… proposed to enhance the clinical efficacy of PDE4 inhibitors. One of these is the use of dual PDE3/4 inhibitors, which in addition to providing superior anti-inflammatory activity when compared to a PDE4 inhibitor alone, will also promote bronchodilatation. The present study demonstrates that …
-
The differential regulation of cyclic AMP phosphodiesterases in T lymphocytes
… PDE2 activity and cyclic AMP specific PDE4 activity were shown to provide the major cyclic AMP hydrolysing activities in murine thymocytes. PDE4 activity predominated (~80% total) in the absence of cyclic GMP. However, on addition of low (10?M) concentrations of cyclic GMP, PDE2 …
Page 1 of 5